While clinical evidence is still emerging, GLP-1s potential dual ability to reduce the risk of comorbidities and stabilize patients with fewer additional drugs positions them as a cornerstone of modern diabetes care
Gallbladder disease risk may be increased with GLP-1 receptor agonists, particularly with substantial weight loss
Stambolija V, Stambolija TP, Holjevac JK, Murselovic T, Radonic J, Duzel V, et al
Bambace, C
PubMed Central, Maintz, L., et al
While primarily intended for research use, these peptides provide valuable insights into slowing biological aging and enhancing cell health through advanced scientific studies